BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16091193)

  • 1. Advances in the treatment of chronic lymphocytic leukemia.
    Lamanna N
    Curr Oncol Rep; 2005 Sep; 7(5):333-8. PubMed ID: 16091193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of chronic lymphocytic leukemia.
    Lamanna N
    Curr Hematol Malig Rep; 2006 Mar; 1(1):43-8. PubMed ID: 20425331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatment strategies in chronic lymphocytic leukemia.
    Weiss MA
    Curr Oncol Rep; 2001 May; 3(3):217-22. PubMed ID: 11296131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the frontline treatment of patients with chronic lymphocytic leukemia.
    Lamanna N
    Curr Hematol Malig Rep; 2010 Jan; 5(1):45-51. PubMed ID: 20425396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
    Aivado M; Schulte K; Henze L; Burger J; Finke J; Haas R
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):19-22. PubMed ID: 12170428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the treatment of chronic lymphocytic leukemia.
    Liu NS; O'Brien S
    Med Oncol; 2004; 21(4):297-304. PubMed ID: 15579912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in chemotherapy for chronic lymphocytic leukemia.
    Wendtner CM; Eichhorst BF; Hallek MJ
    Semin Hematol; 2004 Jul; 41(3):224-33. PubMed ID: 15269882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Vazquez ER; Spigel DR; Raefsky E; Bearden JD; Saez RA; Greco FA
    Cancer; 2008 Mar; 112(6):1288-95. PubMed ID: 18189296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S15-22. PubMed ID: 16720199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine in chronic lymphocytic leukaemia.
    Elter T; Hallek M; Engert A
    Expert Opin Pharmacother; 2006 Aug; 7(12):1641-51. PubMed ID: 16872267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in CLL, chemotherapy, antibodies and transplantation.
    Keating MJ
    Biomed Pharmacother; 2001 Nov; 55(9-10):524-8. PubMed ID: 11769960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia: current and emerging treatment approaches.
    Kay NE; Rai KR; O'Brien S
    Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 22):1-10; quiz 11-2. PubMed ID: 17143256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
    Lamanna N; Weiss MA
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S44-9. PubMed ID: 16549114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
    Schmitt B; Wendtner CM; Bergmann M; Busch R; Franke A; Pasold R; Schlag R; Hopfinger G; Hiddemann W; Emmerich B; Hallek M
    Clin Lymphoma; 2002 Jun; 3(1):26-35. PubMed ID: 12141952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
    Robak T
    Leuk Lymphoma; 2004 Feb; 45(2):205-19. PubMed ID: 15101704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.